Concourse Financial Group Securities, Inc. Tonix Pharmaceuticals Holding Corp. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.46 - $1.3 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$0.29 - $0.57 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$0.53 - $1.9 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$1.58 - $7.36 $0 - $0
0 New
0 $0

About Tonix Pharmaceuticals Holding Corp.

TNXP Quotes by TradingView
  • Ticker TNXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,752,700
  • Market Cap $7.81M
  • Description
  • Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...
More about TNXP
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email